FDA approves study of ATS Medical's heart valve

08/27/2009 | Forbes

The FDA has allowed ATS Medical to conduct a clinical trial to test its ATS 3f Aortic Bioprosthesis heart valve in patients younger than 60 who need to an aortic valve replacement. The device, which functions like a natural cardiac valve, was cleared by the FDA in October.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA